FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 02:27:24 2024-05-23 pm EDT | ||
| 2.34 EUR | -10.34% |
|
| Current month | +100.46% | ||
| 1 month | +108.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 2.34 | -10.34% |
| 24-05-22 | 2.61 | -2.25% |
| 24-05-21 | 2.67 | -1.84% |
| 24-05-20 | 2.72 | +4.62% |
| 24-05-17 | 2.6 | -5.45% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 02:27 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GX8KZD |
| ISIN | DE000GX8KZD7 |
| Date issued | 2022-02-04 |
| Strike | 270.7 $ |
| Maturity | Unlimited |
| Parity | 14.98 : 1 |
| Emission price | 9.91 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 30.53 € |
|---|---|
| Lowest since issue | 0.846 € |
| Spread | 0.02 € |
| Spread % | 0.86% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Certificates
- Certificat
